| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An αIIbβ3 ligand-mimetic murine monoclonal antibody that produces platelet activation by engaging the FcγIIa receptor
|
Wang, Jialing
|
|
|
9 |
14 |
p. 3518-3529
|
article
|
| 2 |
2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease
|
James, Paula D.
|
|
|
9 |
14 |
p. 3553-3555
|
article
|
| 3 |
Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP
|
Nijland, Marcel
|
|
|
9 |
14 |
p. 3530-3539
|
article
|
| 4 |
Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study
|
Sharma, Rubina
|
|
|
9 |
14 |
p. 3479-3494
|
article
|
| 5 |
Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL
|
Ketzer, Franz
|
|
|
9 |
14 |
p. 3441-3454
|
article
|
| 6 |
BMP-2 generates a functional bone marrow niche by inducing the differentiation of local mesenchymal cells into CAR cells
|
Tosa, Ikue
|
|
|
9 |
14 |
p. 3598-3612
|
article
|
| 7 |
Chronic kidney disease in adults with sickle cell trait: a systematic review and meta-analysis
|
Castro-Sesquen, Yagahira E.
|
|
|
9 |
14 |
p. 3644-3657
|
article
|
| 8 |
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years
|
von Drygalski, Annette
|
|
|
9 |
14 |
p. 3543-3552
|
article
|
| 9 |
Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults
|
Perales, Miguel-Angel
|
|
|
9 |
14 |
p. 3502-3517
|
article
|
| 10 |
Evaluating the long-term benefits of hydroxyurea in pediatric sickle cell anemia
|
George, Paul
|
|
|
9 |
14 |
p. 3585-3593
|
article
|
| 11 |
Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations
|
Baranwal, Anmol
|
|
|
9 |
14 |
p. 3395-3407
|
article
|
| 12 |
Getting closer to hemophilia gene therapy for all?
|
Reiss, Ulrike M.
|
|
|
9 |
14 |
p. 3629-3630
|
article
|
| 13 |
High rate of complete responses induced by platinum-based regimen with BTK inhibitors in Richter syndrome
|
Pongas, Georgios
|
|
|
9 |
14 |
p. 3594-3597
|
article
|
| 14 |
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
|
Abedin, Sameem
|
|
|
9 |
14 |
p. 3495-3501
|
article
|
| 15 |
In search of the perfect donor: youth must be served
|
Jones, Richard J.
|
|
|
9 |
14 |
p. 3540-3542
|
article
|
| 16 |
Intrathecal chemotherapy for ciltacabtagene autoleucel–associated movement and neurocognitive toxicity
|
Kelly, Kaitlin
|
|
|
9 |
14 |
p. 3613-3616
|
article
|
| 17 |
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
|
Saha, Satabdi
|
|
|
9 |
14 |
p. 3429-3440
|
article
|
| 18 |
Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix–producing cancer-associated fibroblasts
|
Dessauge, Elise
|
|
|
9 |
14 |
p. 3455-3468
|
article
|
| 19 |
Molecular profiling of primary renal marginal zone lymphoma reveals overlapping features with extranodal marginal zone lymphoma
|
Künstner, Axel
|
|
|
9 |
14 |
p. 3658-3663
|
article
|
| 20 |
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features
|
Fragneau, Rivers
|
|
|
9 |
14 |
p. 3617-3628
|
article
|
| 21 |
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine
|
Zhao, Lin-Pierre
|
|
|
9 |
14 |
p. 3556-3565
|
article
|
| 22 |
Reassessing the Villalta score’s use of signs and symptoms
|
Yale, Steven H.
|
|
|
9 |
14 |
p. 3642-3643
|
article
|
| 23 |
Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage
|
Peshkova, Alina D.
|
|
|
9 |
14 |
p. 3418-3428
|
article
|
| 24 |
Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials
|
Abuhelwa, Ahmad Y.
|
|
|
9 |
14 |
p. 3566-3575
|
article
|
| 25 |
Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
|
Dima, Danai
|
|
|
9 |
14 |
p. 3408-3417
|
article
|
| 26 |
Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis
|
Nath, Karthik
|
|
|
9 |
14 |
p. 3469-3478
|
article
|
| 27 |
Untangling profiles of postthrombotic syndrome using unsupervised machine learning
|
Iding, Aaron F. J.
|
|
|
9 |
14 |
p. 3631-3641
|
article
|
| 28 |
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort
|
Serafin, Andrea
|
|
|
9 |
14 |
p. 3576-3584
|
article
|
Journal description